Register Login
Register to leave comments
  • News bot May 4, 2026, 1:04 p.m.

    📋 ONCOLYTICS BIOTECH INC (ONCY) - Clinical Trial Update

    Filing Date: 2026-05-04

    Accepted: 2026-05-04 09:03:46

    Event Type: Clinical Trial Update

    Event Details:

    ONCOLYTICS BIOTECH INC (ONCY) Announces Clinical Trial Update ONCOLYTICS BIOTECH INC (ONCY) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: signal, Pathway
    • Diseases/Conditions: pelareorep in colorectal cancer, metastatic colorectal cancer (“mCRC”)
    • Collaboration: Biotech® Inc.

    🔬 Clinical Development Pipeline (ONCOLYTICS BIOTECH INC):

    Product Type Development Stage Therapeutic Area Source
    Chemotherapy Drug Phase PHASE1 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Chemotherapy DRUG Phase PHASE1 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Bevacizumab Other Phase PHASE1 KRAS Mutant Metastatic Colorectal Cancer ClinicalTrials.gov
    mFOLFIRINOX Treatment Regimen Drug Phase PHASE1 Anal Cancer Metastatic ClinicalTrials.gov
    Pelareorep Other Phase EARLY_PHASE1 Breast Cancer ClinicalTrials.gov
    Placebo Other Phase PHASE3 Carcinoma, Squamous Cell of the Head and Neck ClinicalTrials.gov
    Paclitaxel Other Phase PHASE3 Carcinoma, Squamous Cell of the Head and Neck ClinicalTrials.gov
    Carboplatin Other Phase PHASE3 Carcinoma, Squamous Cell of the Head and Neck ClinicalTrials.gov
    REOLYSIN Other Phase PHASE3 Carcinoma, Squamous Cell of the Head and Neck ClinicalTrials.gov
    Gemcitabine Other Phase PHASE2 Metastatic Pancreatic Adenocarcinoma ClinicalTrials.gov
    Cisplatin Other Phase PHASE1 Muscle-invasive Transitional Cell Carcinoma of the Bladder ClinicalTrials.gov
    REOLYSIN® Other Phase PHASE1 Muscle-invasive Transitional Cell Carcinoma of the Bladder ClinicalTrials.gov
    Pembrolizumab Other Phase PHASE1 Pancreatic Adenocarcinoma ClinicalTrials.gov
    5-fluorouracil Other Phase PHASE1 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Leucovorin Other Phase PHASE1 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Irinotecan Other Phase PHASE1 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Fluorouracil (5-FU) Other Phase PHASE1 KRAS Mutant Metastatic Colorectal Cancer ClinicalTrials.gov
    Lenalidomide or Pomalidomide Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Trastuzumab Other Phase EARLY_PHASE1 Breast Cancer ClinicalTrials.gov
    Atezolizumab Other Phase EARLY_PHASE1 Breast Cancer ClinicalTrials.gov
    Letrozole Other Phase EARLY_PHASE1 Breast Cancer ClinicalTrials.gov
    Docetaxel Other Phase PHASE2 Non Small Cell Lung Cancer ClinicalTrials.gov
    Docetaxel and Reolysin Other Phase PHASE2 Non Small Cell Lung Cancer ClinicalTrials.gov
    Pemetrexed Other Phase PHASE2 Non Small Cell Lung Cancer ClinicalTrials.gov
    Pemetrexed and Reolysin (and safety run-in) Other Phase PHASE2 Non Small Cell Lung Cancer ClinicalTrials.gov
    Docetaxel and Prednisone Other Phase PHASE2 Prostate Cancer ClinicalTrials.gov
    Docetaxel, Reolysin and Prednisone Other Phase PHASE2 Prostate Cancer ClinicalTrials.gov
    Wild-type Reovirus Other Phase PHASE1 Recurrent Plasma Cell Myeloma ClinicalTrials.gov
    Pharmacological Study Other Phase PHASE1 Recurrent Plasma Cell Myeloma ClinicalTrials.gov
    Laboratory Biomarker Analysis Other Phase PHASE1 Recurrent Plasma Cell Myeloma ClinicalTrials.gov
    Dexamethasone Other Phase PHASE1 Recurrent Plasma Cell Myeloma ClinicalTrials.gov
    Bortezomib Other Phase PHASE1 Recurrent Plasma Cell Myeloma ClinicalTrials.gov
    Folfox plus Bevacizumab Other Phase PHASE2 Colorectal Cancer ClinicalTrials.gov
    Folfox plus Bevacizumab and reolysin Other Phase PHASE2 Colorectal Cancer ClinicalTrials.gov
    Avelumab Other Phase PHASE2 Breast Cancer Metastatic ClinicalTrials.gov
    Trifluridine Tipiracil Other Phase PHASE1 Anal Cancer Metastatic ClinicalTrials.gov
    Gemcitabine and nab-paclitaxel Other Phase PHASE1 Anal Cancer Metastatic ClinicalTrials.gov
    FOLFIRI Other Phase PHASE2 Ras-mutated Metastatic Colorectal Cancer ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ONCOLYTICS BIOTECH INC
    • Ticker Symbol: ONCY

Search

News categories